Orange Health Labs
Venture Round in 2024
Orange Health is a health technology company that facilitates remote diagnostic lab services for patients, allowing doctors to provide real-time care. Its platform focuses on patient-centric home sample collection and testing, aiming to make healthcare more accessible and efficient.
We are revolutionizing the healthcare industry with our state-of-the-art artificial intelligence solutions, specifically designed for medical diagnostics and breast cancer prediction. Our mission is to enhance patient outcomes, streamline medical processes, and safeguard healthcare systems.
Breathe Well-being
Series B in 2023
Breathe Well-being is a health technology company based in India. It offers a clinically proven program for individuals with chronic conditions like diabetes, aiming to help them lose weight and manage their health effectively. The program provides one-on-one coaching, tracking of weight, meals, and activity, along with cognitive behavioral therapy techniques to reduce stress.
Orange Health Labs
Series B in 2022
Orange Health is a health technology company that facilitates remote diagnostic lab services for patients, allowing doctors to provide real-time care. Its platform focuses on patient-centric home sample collection and testing, aiming to make healthcare more accessible and efficient.
SQIN
Pre Seed Round in 2022
SQIN is a leading provider of personalized dermatological treatment, serving over 100,000 patients annually. It offers an AI-powered skin advice app that educates users about skin health and connects them with professional dermatologists for digital consultations. The platform also provides interactive educational content and personalized skin training programs based on individual skin needs.
Sprinter Health
Series A in 2021
Sprinter Health is a mobile healthcare provider that sends full-time nurses and phlebotomists to patients' homes for preventive care services.
Orange Health Labs
Series A in 2021
Orange Health is a health technology company that facilitates remote diagnostic lab services for patients, allowing doctors to provide real-time care. Its platform focuses on patient-centric home sample collection and testing, aiming to make healthcare more accessible and efficient.
Breathe Well-being
Series A in 2021
Breathe Well-being is a health technology company based in India. It offers a clinically proven program for individuals with chronic conditions like diabetes, aiming to help them lose weight and manage their health effectively. The program provides one-on-one coaching, tracking of weight, meals, and activity, along with cognitive behavioral therapy techniques to reduce stress.
Centaur Labs
Series A in 2021
Centaur Labs provides a platform for expert data annotation services, specializing in medical, scientific, and other complex datasets. It leverages a global network of tens of thousands of students and professionals to deliver accurate and scalable solutions.
Veri is a company focused on enhancing metabolic health for health-conscious individuals through innovative technology. It has developed a blood sugar monitoring application that integrates with a sensor to provide real-time tracking of blood sugar levels. The application offers users comprehensive analysis and insights related to their glucose readings, empowering them to make informed decisions about their eating habits. By facilitating a better understanding of what, when, and how to eat, Veri aims to help individuals stabilize their blood sugar levels and lead healthier lifestyles.
Idoven develops an AI-powered cardiology-as-a-service platform that enhances the diagnostic capabilities of cardiologists and non-cardiology clinicians. It partners with prominent organizations like AstraZeneca, Abbott, and GE Healthcare to improve patient care. Idoven has received significant recognition for its innovative technology, including awards from the European Innovation Council and CB Insights.
Nines is a pioneering teleradiology practice that focuses on enhancing patient care through advanced technology. The company develops in-house tools that empower radiologists to provide high-quality diagnostics. Its platform is designed to analyze medical scans for urgent findings that necessitate immediate attention, as well as to identify subtle details that assist in the radiological review process. This innovative approach aims to improve the accuracy of results and overall patient care, setting Nines apart in the field of radiology.
Onco is a healthcare technology company that offers an online platform specifically designed for cancer patients and their families. This platform facilitates personalized treatment advice and comprehensive care management by connecting users with oncologists and other healthcare providers through a mobile application. Onco enables patients to receive unbiased analyses of their treatment plans, along with detailed and personalized reports regarding their condition. By prioritizing connections with hospitals, diagnostic labs, and service providers, Onco ensures that patients have access to essential medical advice and support whenever they need it, thereby enhancing their overall treatment journey.
Centaur Labs
Seed Round in 2019
Centaur Labs provides a platform for expert data annotation services, specializing in medical, scientific, and other complex datasets. It leverages a global network of tens of thousands of students and professionals to deliver accurate and scalable solutions.
Doctolib is an online healthcare platform and management software provider based in Paris. The company offers a patient-facing service that enables users to find nearby health practitioners and book appointments 24/7, and a practitioner-focused software suite that helps clinics manage bookings, organize patient consultations, and reduce missed appointments. Founded in 2013, Doctolib serves a range of medical specialties and aims to improve access to care while increasing efficiency for doctors and clinics, contributing to better work-life balance for practitioners and more convenient care for patients.
Farcast Biosciences, established in 2019, is a clinical diagnostic company based in Boston, Massachusetts, with operations in Bangalore, India. The company specializes in developing and utilizing a proprietary Human Tumor Micro Dynamics (HTMD) platform. This platform preserves the natural state of human tumors through the culture of fresh, unmodified tumor fragments, creating a human tumor microenvironment. Farcast's technology enables oncologists to evaluate individual tumors and predict patient response to treatments before initiating therapy. Additionally, it serves drug developers and researchers by providing accurate and precise models for testing and analysis, facilitating the development of personalized cancer therapies.
Nines is a pioneering teleradiology practice that focuses on enhancing patient care through advanced technology. The company develops in-house tools that empower radiologists to provide high-quality diagnostics. Its platform is designed to analyze medical scans for urgent findings that necessitate immediate attention, as well as to identify subtle details that assist in the radiological review process. This innovative approach aims to improve the accuracy of results and overall patient care, setting Nines apart in the field of radiology.
Doctolib is an online healthcare platform and management software provider based in Paris. The company offers a patient-facing service that enables users to find nearby health practitioners and book appointments 24/7, and a practitioner-focused software suite that helps clinics manage bookings, organize patient consultations, and reduce missed appointments. Founded in 2013, Doctolib serves a range of medical specialties and aims to improve access to care while increasing efficiency for doctors and clinics, contributing to better work-life balance for practitioners and more convenient care for patients.
Farcast Biosciences, established in 2019, is a clinical diagnostic company based in Boston, Massachusetts, with operations in Bangalore, India. The company specializes in developing and utilizing a proprietary Human Tumor Micro Dynamics (HTMD) platform. This platform preserves the natural state of human tumors through the culture of fresh, unmodified tumor fragments, creating a human tumor microenvironment. Farcast's technology enables oncologists to evaluate individual tumors and predict patient response to treatments before initiating therapy. Additionally, it serves drug developers and researchers by providing accurate and precise models for testing and analysis, facilitating the development of personalized cancer therapies.
Doctolib is an online healthcare platform and management software provider based in Paris. The company offers a patient-facing service that enables users to find nearby health practitioners and book appointments 24/7, and a practitioner-focused software suite that helps clinics manage bookings, organize patient consultations, and reduce missed appointments. Founded in 2013, Doctolib serves a range of medical specialties and aims to improve access to care while increasing efficiency for doctors and clinics, contributing to better work-life balance for practitioners and more convenient care for patients.
Forus Health
Series B in 2014
Forus Health is an Indian technology company based in Bangalore, founded in 2010 to address global eye-care challenges through innovative products and deployment models that emphasize inclusivity. It operates a full-stack digital ophthalmology platform that delivers end-to-end screening and diagnosis from any location, combining ophthalmic drugs, non-mydriatic imaging devices and other pre-screening diagnostics to improve access and affordability of eye care. The platform includes a cloud-based telemedicine tool that integrates imaging devices, ophthalmologists, optometrists, and artificial intelligence engines to support remote diagnosis and treatment planning, enabling patients to receive care online and offline at a lower cost. Through its solutions, the company aims to expand access to ophthalmology services and drive better outcomes.
Farcast Biosciences, established in 2019, is a clinical diagnostic company based in Boston, Massachusetts, with operations in Bangalore, India. The company specializes in developing and utilizing a proprietary Human Tumor Micro Dynamics (HTMD) platform. This platform preserves the natural state of human tumors through the culture of fresh, unmodified tumor fragments, creating a human tumor microenvironment. Farcast's technology enables oncologists to evaluate individual tumors and predict patient response to treatments before initiating therapy. Additionally, it serves drug developers and researchers by providing accurate and precise models for testing and analysis, facilitating the development of personalized cancer therapies.
Forus Health
Series A in 2012
Forus Health is an Indian technology company based in Bangalore, founded in 2010 to address global eye-care challenges through innovative products and deployment models that emphasize inclusivity. It operates a full-stack digital ophthalmology platform that delivers end-to-end screening and diagnosis from any location, combining ophthalmic drugs, non-mydriatic imaging devices and other pre-screening diagnostics to improve access and affordability of eye care. The platform includes a cloud-based telemedicine tool that integrates imaging devices, ophthalmologists, optometrists, and artificial intelligence engines to support remote diagnosis and treatment planning, enabling patients to receive care online and offline at a lower cost. Through its solutions, the company aims to expand access to ophthalmology services and drive better outcomes.
Perfint Healthcare
Series C in 2012
Perfint Healthcare is a leading developer of medical devices that specialize in planning and targeting solutions for image-guided interventional procedures, focusing primarily on oncology and pain management. The company's innovative products are designed to facilitate minimally invasive treatments, such as biopsies, drug delivery, ablation, drainage, and fine needle aspiration. These devices are utilized by radiologists in some of the world’s top hospitals, enhancing the capabilities of healthcare professionals to improve patient outcomes in both cancer-related and non-cancer-related pain management. Perfint's solutions are recognized for their quality and effectiveness, as evidenced by their CE marking, which signifies compliance with European health and safety standards.
Perfint Healthcare
Series B in 2010
Perfint Healthcare is a leading developer of medical devices that specialize in planning and targeting solutions for image-guided interventional procedures, focusing primarily on oncology and pain management. The company's innovative products are designed to facilitate minimally invasive treatments, such as biopsies, drug delivery, ablation, drainage, and fine needle aspiration. These devices are utilized by radiologists in some of the world’s top hospitals, enhancing the capabilities of healthcare professionals to improve patient outcomes in both cancer-related and non-cancer-related pain management. Perfint's solutions are recognized for their quality and effectiveness, as evidenced by their CE marking, which signifies compliance with European health and safety standards.
Farcast Biosciences, established in 2019, is a clinical diagnostic company based in Boston, Massachusetts, with operations in Bangalore, India. The company specializes in developing and utilizing a proprietary Human Tumor Micro Dynamics (HTMD) platform. This platform preserves the natural state of human tumors through the culture of fresh, unmodified tumor fragments, creating a human tumor microenvironment. Farcast's technology enables oncologists to evaluate individual tumors and predict patient response to treatments before initiating therapy. Additionally, it serves drug developers and researchers by providing accurate and precise models for testing and analysis, facilitating the development of personalized cancer therapies.
Perfint Healthcare
Series A in 2007
Perfint Healthcare is a leading developer of medical devices that specialize in planning and targeting solutions for image-guided interventional procedures, focusing primarily on oncology and pain management. The company's innovative products are designed to facilitate minimally invasive treatments, such as biopsies, drug delivery, ablation, drainage, and fine needle aspiration. These devices are utilized by radiologists in some of the world’s top hospitals, enhancing the capabilities of healthcare professionals to improve patient outcomes in both cancer-related and non-cancer-related pain management. Perfint's solutions are recognized for their quality and effectiveness, as evidenced by their CE marking, which signifies compliance with European health and safety standards.
US Pathology Labs
Series E in 2002
US Pathology Labs provider of anatomic pathology and oncology testing services with a focus on the outpatient market.
Biostate AI specializes in developing a comprehensive biotechnology data aggregation and analysis platform. This platform integrates diverse data sources such as clinical trial results, regulatory information, and scientific publications, providing tools for data visualization, trend analysis, and predictive insights. The company's solution enables researchers to assess drug development progress and make evidence-based decisions, ultimately benefiting human health.
WellTheory operates a virtual care platform focused on autoimmune and inflammatory health. It offers personalized nutrition and lifestyle guidance, root-cause assessments, and connects each member with a multidisciplinary care team that may include dietitians, health coaches, and care coordinators. The platform supports members with live coaching, unlimited messaging, educational content, and community connection, with access to advanced testing as needed. For employers and payers, WellTheory provides an enterprise solution that integrates with existing benefits systems, manages implementation, communications, and reporting, and seeks to reduce autoimmune-related medical spend. The service blends community care with dietary and lifestyle changes to deliver personalized insights and evidence-based recommendations within a membership framework.
Sprinter Health is a mobile healthcare provider that sends full-time nurses and phlebotomists to patients' homes for preventive care services.